<DOC>
	<DOCNO>NCT01439737</DOCNO>
	<brief_summary>Asthma chronic inflammatory airway disease . Significant heterogeneity exist clinical manifestation treatment responses patient . Metabolomics large-scale approach monitor many possible compound involve cellular process single assay derive metabolic profile . Compared genomics proteomics , metabolomics reflect change phenotype therefore function . Up , study evaluate role metabolomic analysis diagnosis prognostic evaluation airway disorder . Collection exhale breath condensate ( EBC ) newly develop , noninvasive method may allow clinician researcher assess biochemical profile alveolar line fluid . This study apply metabolomics examine biomarkers EBCs , serum urine specimens adult asthmatic .</brief_summary>
	<brief_title>Metabolomic Analysis Exhaled Breath Condensate Asthmatics</brief_title>
	<detailed_description>The aim study : 1 . Metabolomic profile exhale breath condensate ( EBC ) , serum urine specimen adult asthmatic ; 2 . Correlation metabolomic profile specimens severity control asthma ; 3 . Comparing metabolomic profile asthmatic different phenotype endotypes ; 4.Comparing metabolomic profile obtain asthmatic stable acute exacerbation period ; 5 . Comparing metabolomic profile asthmatic inhale corticosteroid therapy .</detailed_description>
	<criteria>1 . 2090 year 2 . Diagnosis asthma base GINA guideline 1 . Patient cancer 2 . Patient longterm ventilator use</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Asthma</keyword>
	<keyword>metabolomics</keyword>
	<keyword>exhale breath condensate</keyword>
</DOC>